PURNIMA TEEGAVARAPU

Concepts (36)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
4
2017
420
0.870
Why?
Sarcoma, Ewing
1
2017
120
0.470
Why?
Neuroendocrine Tumors
1
2014
69
0.390
Why?
Safety-net Providers
1
2025
86
0.210
Why?
Cystitis
1
2005
47
0.210
Why?
Carcinoma, Renal Cell
2
2016
222
0.200
Why?
Sulfonamides
2
2016
294
0.200
Why?
Eosinophilia
1
2005
107
0.200
Why?
Pyrimidines
2
2016
452
0.190
Why?
Hodgkin Disease
1
2025
307
0.190
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
56
0.120
Why?
Antineoplastic Agents
2
2016
1792
0.110
Why?
Angiogenesis Inhibitors
1
2015
112
0.110
Why?
TOR Serine-Threonine Kinases
1
2015
427
0.100
Why?
Retrospective Studies
5
2025
17633
0.100
Why?
Nephrectomy
1
2014
156
0.100
Why?
Middle Aged
5
2025
28338
0.090
Why?
Combined Modality Therapy
1
2014
1233
0.080
Why?
Adult
5
2025
31093
0.080
Why?
Treatment Outcome
4
2025
12854
0.080
Why?
Young Adult
3
2025
9970
0.070
Why?
Aged
4
2025
20854
0.060
Why?
Indazoles
2
2016
35
0.060
Why?
Male
5
2025
64493
0.060
Why?
Cystoscopy
1
2005
41
0.060
Why?
Female
5
2025
70272
0.050
Why?
Prognosis
1
2014
4900
0.050
Why?
Urinalysis
1
2005
74
0.050
Why?
Humans
6
2025
130357
0.040
Why?
Algorithms
1
2005
1680
0.030
Why?
Aged, 80 and over
2
2016
6760
0.030
Why?
Disease-Free Survival
1
2016
900
0.030
Why?
Neoplasm Metastasis
1
2016
706
0.030
Why?
Survival Analysis
1
2016
1499
0.020
Why?
Drug Therapy, Combination
1
2015
1164
0.020
Why?
Adolescent
1
2025
20724
0.020
Why?
TEEGAVARAPU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (36)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_